Kinase inhibitors and method of treating cancer
Abstract:
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
Public/Granted literature
Information query
Patent Agency Ranking
0/0